RELAPSED

作品数：95被引量：150H指数：7
导出分析报告
相关领域：医药卫生农业科学更多>>
相关作者：关涛苏丽萍马莉赵瑾王晶荣更多>>
相关机构：上海市第一人民医院绍兴文理学院绍兴市人民医院浙江省人民医院更多>>
相关期刊：《Asian Journal of Andrology》《Journal of Integrative Medicine》《Open Journal of Blood Diseases》《Cellular & Molecular Immunology》更多>>
相关基金：国家自然科学基金北京市自然科学基金广东省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Chinese Medical Journalx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma
《Chinese Medical Journal》2024年第19期2308-2324,共17页Chengji Wang Liang Wang 
funded by Beijing Physician Scientist Training Project(No.BJPSTP-2024-01)to Liang Wang.
Natural killer/T cell lymphoma(NKTCL)is a malignant tumor originating from NK or T cells,characterized by its highly aggressive and heterogeneous nature.NKTCL is predominantly associated with Epstein-Barr virus infect...
关键词：Natural killer/T cell lymphoma Epstein-Barr virus Chemotherapy resistance ASPARAGINASE IMMUNOTHERAPY 
Chidamide plus prednisone,cyclophosphamide,and thalidomide for relapsed or refractory peripheral T-cell lymphoma:A multicenter phase II trial
《Chinese Medical Journal》2024年第13期1576-1582,共7页Jinhua Liang Li Wang Xiaodong Wang Guohui Cui Jianfeng Zhou Tongyao Xing Kaixin Du Jingyan Xu Luqun Wang Rong Liang Biyun Chen Jian Cheng Haorui Shen Jianyong Li Wei Xu 
National Natural Science Foundation of China(Nos.81770166,81700193,82170186,and 81720108002);Jiangsu Province’s Medical Elite Programme(No.ZDRCA2016022);Project of the National Key Clinical Specialty,the Jiangsu Provincial Special Program of Medical Science(No.BE2017751);National Science and Technology Major Project(No.2018ZX09734007);China Postdoctoral Science Foundation(No.2021M691336);Jiangsu Postdoctoral Science Foundation(No.2021K083A)
Background:Although the treatment of peripheral T-cell lymphoma(PTCL)has undergone advancements during the past several years,the response rate and long-term effects with respect to patients with PTCL remain unsatisfa...
关键词：Peripheral T-cell lymphoma CHIDAMIDE PREDNISONE CYCLOPHOSPHAMIDE THALIDOMIDE All-oral regimen 
Comparison of pathological findings between patients with relapsed and non-relapsed immunoglobin G4-related disease
《Chinese Medical Journal》2022年第4期465-467,共3页Hui Lu Shan Wang Mu Wang Xiaowei Liu Linyi Peng Jiaxin Zhou Jieqiong Li Zheng Liu Xuan Luo Yu Peng Yunyun Fei Yan Zhao Xiaofeng Zeng Ruie Feng Wen Zhang 
This work was supported by grants from the National Natural Science Foundation of China(Nos.81771757,81771780,82071839);the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences(No.NWB20203346);Capital’s Funds for Health Improvement and Research(No.2020-2-4017);Beijing Municipal Science and Technology Commission(No.Z201100005520023)。
Immunoglobin(Ig)G4-related disease(IgG4-RD)is an immune-mediated fibroinflammatory condition characterized by elevated serum IgG4 levels and multi-organ involvement.The characteristic histological findings of IgG4-RD ...
关键词：IGG4 RELAPSE INVOLVEMENT 
CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
《Chinese Medical Journal》2022年第1期98-100,共3页Qianwen Xu Hui Xu Lei Xue Min Wang Guiwang Pan Xuhan Zhang Kaidi Song Wen Yao Xiang Wan Juan Tong Huilan Liu Hanying Xu Xin Liu Xiaoyu Zhu Zimin Sun Lin Yang Xingbing Wang 
The work was supported by grants from the Science and Technology Planning Project of Anhui Province,China(No.1604a0802071);the Major Science and Technology Projects of Anhui Province,China(No.18030801126)。
To the Editor:Umbilical cord blood transplant(UCBT)serves as an alternative option for treating patients with B cell acute lymphoblastic leukemia(ALL),in the absence of a compatible donor.However,disease recurrence pr...
关键词：PATIENTS RELAPSE LYMPHOBLASTIC 
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study被引量：3
《Chinese Medical Journal》2021年第11期1299-1309,共11页Yuan-Kai Shi Xiao-Nan Hong Jian-Liang Yang Wei Xu Hui-Qiang Huang Xiu-Bin Xiao Jun Zhu Dao-Bin Zhou Xiao-Hong Han Jian-Qiu Wu Ming-Zhi Zhang Jie Jin Xiao-Yan Ke Wei Li De-Pei Wu Shen-Miao Yang Xin Du Yong-Qian Jia Ai-Chun Liu Dai-Hong Liu Zhi-Xiang Shen Lian-Sheng Zhang Leonard James Edward Hellriegel 
by the Teva Branded Pharmaceutical Products R&D Inc.
Background:Bendamustine was approved in China on May 26th,2019 by the National Medical Product Administration for the treatment of indolent B-cell non-Hodgkin lymphoma(NHL).The current study was the registration trial...
关键词：BENDAMUSTINE Non-Hodgkin lymphoma B-cell malignancy Relapsed disease Clinical trial 
Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea被引量：3
《Chinese Medical Journal》2019年第7期846-848,共3页Jun-Ling Fu Tong Wang Xin-Hua Xiao 
To the Editor:Neonatal diabetes mellitus(NDM)is defined as diabetes diagnosed within 6 months after birth and occurs in approximately one in every 90,000 to 160,000 live births,with an 80%yield due to a known genetic ...
关键词：NEONATAL diabetes mellitus(NDM) transient(TNDM) permanent(PNDM) 
Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation被引量：5
《Chinese Medical Journal》2012年第11期1952-1959,共8页QIN Xiao-ying LI Guo-xuan QIN Ya-zhen WANG Yu WANG Feng-rong LIU Dai-hong XU Lan-ping CHEN Huan HAN Wei WANG Jing-zhi ZHANG Xiao-hui LI Jin-lan LI Ling-di LIU Kai-yan HUANG Xiao-jun 
Background Chimerism analysis is an important tool for the surveillance of post-transplant engraftment. It offers the possibility of identifying impending graft rejection and recurrence of underlying malignant or non-...
关键词：CHIMERISM graft rejection  hematopoietic stem cell transplantation  polymerase chain reaction  single nucleotide polymorphism 
Infusions of recipient-derived cytokine-induced killer cells of donor origin eradicated residual disease in a relapsed leukemia patient after allo-hematopoietic stem cell transplantation被引量：5
《Chinese Medical Journal》2012年第9期1669-1671,共3页ZHONG Zhao-dong LUO Yi ZOU Ping ZHENG Jin-e YAO Jun-xia HUANG Shi-ang ZHOU Dong-feng YOU Yong 
A female patient diagnosed with acute myelocytic leukemia M5a （AML-M5a） relapsed 986 days after her allogeneic peripheral blood stem cell transplantation （alIo-PBSCT） from an unrelated male donor with matched huma...
关键词：cytokine-induced killer cells stem cell transplantation relapsed leukemia minor residual disease donor lymphocyte infusion 
Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China被引量：24
《Chinese Medical Journal》2011年第19期2969-2974,共6页YUAN Zhen-gang JIN Jie HUANG Xiao-jun LI Yan CHEN Wen-ming LIU Zhuo-gang CHEN Xie-qun SHEN Zhi-xiang HOU Jian 
Background Although previous clinical study revealed that bortezomib combined with dexamethasone had improved the outcomes of relapsed or refractory multiple myeloma （RRMM）, the optimal dose combinations of bortezom...
关键词：DEXAMETHASONE multiple myeloma relapsed or refractory multiple myeloma 
Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin＇s lymphoma被引量：5
《Chinese Medical Journal》2010年第22期3206-3211,共6页YANG Xi-gui JIANG Chao 
This study was supported by a grant from the Province Natural Science Foundation of Shandong （No. Y2007C 148）.
Background The prognosis is poor for patients with relapsed or refractory non-Hodgkin＇s lymphoma （NHL）. The main reason for poor prognosis is multidrug resistance （MDR）, for which the main phenotype is overexpres...
关键词：lymphoma  non-Hodgkin drug resistance  multiple LIGUSTRAZINE treatment efficacy toxicity 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部